Investor Moves
| Investor | Portfolio Value | Portfolio Change | Position Change | Avg Buy Price | Current Price |
|---|---|---|---|---|---|
Steven CohenPoint72 $3.5M240.8k shares AddQ1 2026 $3.0M $14.46 $14.45 | |||||
Ken GriffinCitadel Advisors $1.3M91.6k shares TrimQ1 2026 $1.2M $14.46 $14.45 | |||||
Ken GriffinCitadel Advisors $1.1M AddQ3 2025 $1.1M -- $14.45 | |||||
News
globenewswire.comNew REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemiaglobenewswire.comMay 27
zacks.comIOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%zacks.comMay 8
zacks.comAll You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buyzacks.comMay 5
zacks.comAmarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Yzacks.comApr 30
seekingalpha.comAmarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcriptseekingalpha.comApr 29